London & Partners, the Mayor of London’s international promotional company, has today announced its new partnership with two cancer charities, The Brain Tumour Charity and Pancreatic Cancer UK.
The two charities topped a London & Partners’ staff poll to decide who the company supports. As well as fundraising events and use of volunteer days, staff will also have the opportunity to share skills and learning that will deliver long-term value to both charities.
Andrew Cooke, Acting CEO of London & Partners, said: “We are delighted to announce our new partnership with The Brain Tumour Charity and Pancreatic Cancer UK. In addition to fundraising and volunteering events, our partnership also signifies a wider commitment to use our time and skills to deliver meaningful advice, knowledge sharing and mentoring on projects in areas such as communications, digital, HR, research and insights.”
Geraldine Pipping, Director of Fundraising at The Brain Tumour Charity, said: “We are grateful to London & Partners for choosing The Brain Tumour Charity as one of their first charity partners. We are looking forward to working alongside the team and are excited to see how our partnership unfolds. Through partnerships with organisations like London & Partners, we are able to offer vital support to patients and families, invest in crucial research to help us see the breakthroughs we urgently need, and be a voice for everyone affected by the disease.”
Sue Collins, Interim Director of Fundraising and Marketing at Pancreatic Cancer UK, said: “We are incredibly delighted and so grateful that the staff at London & Partners have chosen to support Pancreatic Cancer UK as their charity partner. Pancreatic cancer has the lowest survival rate of the 21 most common cancers, with only five per cent of people diagnosed living for five years or more. We receive no government funding and rely 100% on voluntary donations, so it’s only through the efforts of companies like London & Partners that we can change these shocking statistics in the future.”
The new partnership was officially launched on 17 November to mark World Pancreatic Cancer Awareness Day.